SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.
Silvia CagninPatrizia PontissoAndrea MartiniPublished in: Cancers (2024)
SerpinB3, a member of the serine-protease inhibitor family, has emerged as a crucial player in various physiological and pathological processes. Initially identified as an oncogenic factor in squamous cell carcinomas, SerpinB3's intricate involvement extends from fibrosis progression and cancer to cell protection in acute oxidative stress conditions. This review explores the multifaceted roles of SerpinB3, focusing on its implications in fibrosis, metabolic syndrome, carcinogenesis and immune system impairment. Furthermore, its involvement in tissue protection from oxidative stress and wound healing underscores its potential as diagnostic and therapeutic tool. Recent studies have described the therapeutic potential of targeting SerpinB3 through its upstream regulators, offering novel strategies for cancer treatment development. Overall, this review underscores the importance of further research to fully elucidate the mechanisms of action of SerpinB3 and to exploit its therapeutic potential across various medical conditions.
Keyphrases
- squamous cell
- oxidative stress
- metabolic syndrome
- healthcare
- dna damage
- public health
- wound healing
- transcription factor
- ischemia reperfusion injury
- mental health
- single cell
- liver failure
- signaling pathway
- risk assessment
- uric acid
- papillary thyroid
- mesenchymal stem cells
- skeletal muscle
- adipose tissue
- climate change
- young adults
- human health
- heat stress
- protein kinase
- liver fibrosis